Clinical Trials Directory

Trials / Unknown

UnknownNCT03959280

CPAP, Nutrition & Exercise Against Sleep Apnea

Tailored Intervention on Nutrition and Exercise for Obstructive Sleep Apnea Patients Treated With CPAP

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Raphael Heinzer · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.

Detailed description

While the specific impact of obstructive sleep apnea (OSA) on quality of life is well established, the impact of CPAP therapy on quality of life remains unclear. Yet, improving the quality of life of OSA patient is one of the main targets of treatment. Both exercise and healthy diet are recommended in the management of overweight and obesity. This should improve quality of life as well as comorbidities associated with sleep apnea.

Conditions

Interventions

TypeNameDescription
OTHERTailored intervention* The exercise program consists of 2 x 1.5-hour supervised nordic walking sessions weekly during 12 weeks and 1-hour unsupervised moderate physical activity per week from week 4. * The diet intervention includes one face-to-face consultation with a dietician and one telephone-based contact monthly, i.e. 6 diet interventions for 12 weeks. * Behavioural changes techniques will be included in diet and exercise interventions.
OTHERControlThis intervention will include tailored instruction on CPAP use and standard advices on physical activity and nutrition at CPAP initiation.

Timeline

Start date
2019-08-21
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-05-22
Last updated
2021-08-09

Locations

2 sites across 2 countries: France, Switzerland

Source: ClinicalTrials.gov record NCT03959280. Inclusion in this directory is not an endorsement.